Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term \"Immune system and tissue cells\" collectively refers to the extremely diverse populations of cells within the immune system (such as T cells, B cells, NK cells, neutrophils, monocytes, dendritic cells, mast cells, and macrophages) as well as other tissue-resident cells that interact with or are influenced by immune activity[1][2][3][4][5][6]. This grouping is not a single therapeutic target but describes the complex interplay of cells responsible for identifying and removing pathogens, maintaining tissue integrity, mediating inflammatory responses, and orchestrating both innate and adaptive immune responses in various tissues throughout the body[1][2][5]. Each cell type within this category has distinct molecular targets and functions—for example, T cell receptors, B cell receptors, cytokine receptors, etc.—and plays specific roles in health and disease, but \"Immune system and tissue cells\" as a phrase does not map to a single molecular entity useful for clinical targeting[1][2][3][4][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune system and tissue cells.